Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness.
Neagoe C, Opitz CA, Makarenko I, Linke WA. Neagoe C, et al. J Muscle Res Cell Motil. 2003;24(2-3):175-89. doi: 10.1023/a:1026053530766. J Muscle Res Cell Motil. 2003. PMID: 14609029
There is also a significant gradient of N2BA:N2B ratio in a given heart, from basal to apical; transmural ratio differences are less distinct. (2) Skeletal muscles can express longer or shorter I-band-titin (N2A-isoform) to achieve lower or higher titin-derived stiffness, …
There is also a significant gradient of N2BA:N2B ratio in a given heart, from basal to apical; transmural ratio differences are less distinc …
Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles.
Prado LG, Makarenko I, Andresen C, Krüger M, Opitz CA, Linke WA. Prado LG, et al. J Gen Physiol. 2005 Nov;126(5):461-80. doi: 10.1085/jgp.200509364. Epub 2005 Oct 17. J Gen Physiol. 2005. PMID: 16230467 Free PMC article.
Plots of titin size versus percentage of fiber type or MHC isoform (I-IIB-IIA-IID) determined by myofibrillar ATPase staining and gel electrophoresis revealed modest correlations with the type I fiber and MHC-I proportions. ...
Plots of titin size versus percentage of fiber type or MHC isoform (I-IIB-IIA-IID) determined by myofibrillar ATPase staining and gel …
Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.
Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke WA. Makarenko I, et al. Circ Res. 2004 Oct 1;95(7):708-16. doi: 10.1161/01.RES.0000143901.37063.2f. Epub 2004 Sep 2. Circ Res. 2004. PMID: 15345656
STM and STS studies of topological n-type (Bi, In)2(Te, Se, S)3 thermoelectrics.
Lukyanova LN, Makarenko IV, Usov OA. Lukyanova LN, et al. Among authors: makarenko iv. J Phys Condens Matter. 2020 Jul 23;32(46):465701. doi: 10.1088/1361-648X/aba8c8. Online ahead of print. J Phys Condens Matter. 2020. PMID: 32702688
The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
Farnum SO, Makarenko I, Madden L, Mazhnaya A, Marcus R, Prokhorova T, Bojko MJ, Rozanova J, Dvoriak S, Islam Z, Altice FL. Farnum SO, et al. Among authors: makarenko i. Addiction. 2020 May 19. doi: 10.1111/add.15115. Online ahead of print. Addiction. 2020. PMID: 32428276
Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus®): a randomized open-label clinical trial.
Karonova TL, Mosikian AA, Mayorov AY, Makarenko IE, Zyangirova ST, Afonkina OA, Belikova TM, Zalevskaya AG, Khokhlov AL, Drai RV. Karonova TL, et al. Among authors: makarenko ie. J Comp Eff Res. 2020 Mar;9(4):263-273. doi: 10.2217/cer-2019-0136. Epub 2020 Feb 6. J Comp Eff Res. 2020. PMID: 32027167
Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes.
Makarenko I, Pykalo I, Springer SA, Mazhnaya A, Marcus R, Filippovich S, Dvoriak S, Altice FL. Makarenko I, et al. J Subst Abuse Treat. 2019 Sep;104:34-41. doi: 10.1016/j.jsat.2019.05.008. Epub 2019 May 10. J Subst Abuse Treat. 2019. PMID: 31370983
118 results
Jump to page
Feedback